Denator AB Expands and Strengthens Commercial Operations
News Mar 08, 2010
Denator AB announced that the company has expanded and strengthened its Commercial operations group in Europe through the appointment of Patrik Bjoorn as Application Specialist with the responsibility for Technical Support.
Patrik joins Denator from Biolin Scientific where he worked as Senior Sales and Application specialist with the responsibility of, amongst other things, education of sales and application personnel especially at the 15+ distribution partners of Biolin Scientific. Prior to that, Patrik worked for several years at Q-Sense with establishing a novel Swedish research technology on the global market. He held positions as Sales Director and President of the company’s US branch.
Patrik Bjoorn says: "Denator’s product portfolio is in a very exciting stage of evolution and it is great to become part of the team at such an active time.”
Olof Skold, CEO at Denator, states: “We are delighted to be able to strengthen our Commercial operations group with such a highly experienced individual as Patrik, who has proven his abilities in several successful ventures within the biotech industry. Our products are becoming increasingly well-established in the proteomics market hence our decision to increase our personnel to ensure that we continue to provide high quality customer assistance.”
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Porvair Sciences Makes Strategic Appointment for US Microplate BusinessNews
Porvair Sciences and J.G. Finneran Associates are pleased to announce the appointment of Bob Brino as OEM Business Development Manager for their microplate and sample prep product lines.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018